Utility of systemic brigatinib therapy in tumour recurrence of choroid metastasis from non-small cell lung carcinoma. Kim RS, Nguyen MK, Card KR, Shields CL, et al. Can J Ophthalmol 2024;59:e397-e399.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Kim RS, Nguyen MK, Card KR, Shields CL, et al. Utility of systemic brigatinib therapy in tumour recurrence of choroid metastasis from non-small cell lung carcinoma. Can J Ophthalmol 2024;59:e397-e399.
PMID: 37236265